BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 12, 2025
See today's BioWorld Asia
Home
» Chugai seeking Xeloda approval in Japan for use in stomach cancer
To read the full story,
subscribe
or
sign in
.
Chugai seeking Xeloda approval in Japan for use in stomach cancer
Dec. 24, 2014
By
Catherine Makino
TOKYO – Japan, with the world's third-highest rate of stomach cancer behind Mongolia and the Republic of Korea, will soon have another combination drug mix to help treat the disease.
BioWorld Asia